1
|
Alattar K, Dodhia S, Huang CY, Neves JB, Haris A. Intracardiac diffuse large B-cell lymphoma: an unexpected diagnosis. BMJ Case Rep 2024; 17:e259242. [PMID: 38914528 DOI: 10.1136/bcr-2023-259242] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/26/2024] Open
Abstract
Intracardiac lymphomas are exceedingly rare accounting for only 1% of all primary cardiac tumours. Historically, due to their insidious development and non-specific clinical presentation, the diagnosis has been challenging with most cases being confirmed on post-mortem examination. Our case report details the experience of a previously fit and active woman in her 60s who presented with gradual onset exertional dyspnoea. Through a series of multimodal imaging tools (including echocardiogram, cardiac MRI, CT and positron emission tomography-CT) and biopsy, we confirmed the diagnosis of intracardiac diffuse large B-cell lymphoma. Our patient was managed with chemotherapy and went on to demonstrate excellent radiological response with near-complete resolution of the intracardiac mass. Subjectively, our patient reported significant improvement in exercise tolerance within weeks of commencing treatment.
Collapse
MESH Headings
- Humans
- Lymphoma, Large B-Cell, Diffuse/diagnosis
- Lymphoma, Large B-Cell, Diffuse/drug therapy
- Lymphoma, Large B-Cell, Diffuse/diagnostic imaging
- Lymphoma, Large B-Cell, Diffuse/pathology
- Female
- Heart Neoplasms/diagnostic imaging
- Heart Neoplasms/drug therapy
- Middle Aged
- Antineoplastic Combined Chemotherapy Protocols/therapeutic use
- Echocardiography
- Dyspnea/etiology
- Magnetic Resonance Imaging
- Tomography, X-Ray Computed
- Cyclophosphamide/therapeutic use
- Positron Emission Tomography Computed Tomography
- Diagnosis, Differential
- Doxorubicin/therapeutic use
- Biopsy
Collapse
|
2
|
Qiang Y, Zeng K, Zhang B, Guan R, Liu Y, Liu Z, Xu H, Zhang X, Ren Y, Deng B, Yang Y. Atypical location of primary cardiac lymphoma in the left heart with atypical clinical presentation: A case report and literature review. Front Surg 2023; 9:1036519. [PMID: 36726943 PMCID: PMC9885797 DOI: 10.3389/fsurg.2022.1036519] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/04/2022] [Accepted: 10/24/2022] [Indexed: 01/18/2023] Open
Abstract
Background Primary cardiac lymphoma (PCL) is a rare and aggressive cardiac tumor with very poor prognosis that occurs mostly in the right cardiac cavity. Early diagnosis and treatment may improve its prognosis. In the present report, we describe the diagnosis and treatment of a primary cardiac diffuse large B-cell lymphoma (PC-DLBCL) with atypical location and clinical presentation. Additionally, a literature review was conducted to summarize the current knowledge of the disease. Case Presentation A 71-year-old man visited his local hospital because of syncope, recurrent chest tightness, shortness of breath, palpitations, and profuse sweating for more than 20 days. Chest radiography revealed a mediastinal mass. Cardiac computed tomography (CT) showed multiple enlarged mediastinal lymph nodes. Transthoracic echocardiography (TTE) showed a cardiac mass in the posterior-inferior wall of the left atrium. He was then transferred to our hospital for positron emission tomography-CT (PET-CT) which showed active uptake of fluorodeoxyglucose both in the cardiac mass and in the multiple enlarged mediastinal lymph nodes. Biopsy of the enlarged mediastinal lymph nodes was carried out by using video-assisted thoracic surgery (VATS) technique, and pathological examination confirmed the subtype of PC-DLBCL, Stage IV, NCCN IPI 3. Therefore, the patient received a combination of chemotherapy and immunotherapy with R-CDOP (rituximab, cyclophosphamide, liposome doxorubicin, vincristine, and prednisone). After four courses of treatment in 4 months, the cardiac lymphoma and the enlarged mediastinal lymph nodes achieved complete remission with mild side effects of the chemotherapy. Conclusion Early diagnosis and a precise choice of chemotherapy and immunotherapy based on cardiac imaging and pathological examination may improve the prognosis of PC-DLBCL in an atypical location.
Collapse
Affiliation(s)
- Yongjia Qiang
- Department of Cardiovascular Surgery, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangdong, China
| | - Kuan Zeng
- Department of Cardiovascular Surgery, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangdong, China
| | - Bin Zhang
- Department of Cardiovascular Surgery, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangdong, China,Guangdong Provincial Key Laboratory of Epigenetics and Gene Regulation of Malignant Tumors, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangdong, China
| | - Ruicong Guan
- Department of Cardiovascular Surgery, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangdong, China,Guangdong Provincial Key Laboratory of Epigenetics and Gene Regulation of Malignant Tumors, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangdong, China
| | - Yuqiang Liu
- Department of Cardiovascular Surgery, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangdong, China
| | - Zhuxuan Liu
- Department of Cardiovascular Surgery, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangdong, China
| | - Haohua Xu
- Department of Cardiovascular Surgery, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangdong, China
| | - Xinyi Zhang
- Department of Cardiovascular Surgery, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangdong, China
| | - Yanting Ren
- Department of Pathology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangdong, China
| | - Baoping Deng
- Department of Vascular Surgery, The Fifth Affiliated Hospital, Southern Medical University, Guangdong, China,Correspondence: Yanqi Yang Baoping Deng
| | - Yanqi Yang
- Department of Cardiovascular Surgery, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangdong, China,Department of Cardiothoracic Surgery, University Hospital, Linköping University, Linköping, Sweden,Correspondence: Yanqi Yang Baoping Deng
| |
Collapse
|
3
|
Tazi I, Benmoussa A, Boufarissi FZ, Sifsalam M, Lahlimi FZ. [Non-Hodgkin cardiac lymphomas]. Ann Cardiol Angeiol (Paris) 2021; 70:237-244. [PMID: 34274110 DOI: 10.1016/j.ancard.2021.06.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/06/2020] [Accepted: 06/08/2021] [Indexed: 10/20/2022]
Abstract
Cardiac non-Hodgkin lymphoma (CNHL) is a rare extranodal lymphoma with a poor prognosis. Secondary cardiac lymphoma is more frequent than primary cardiac lymphoma. CNHL often involves the right side of the heart. Diagnosis of CNHL can be suggested by echocardiography and magnetic resonance imaging. Cytological examination of pericardial fluid or histological of cardiac tissue is essential. The majority of cases are diffuse B-cell lymphoma. A prompt immediate diagnosis and early treatment are essential for better outcome. Management should be individualized and the most effective treatment is chemotherapy containing anthracycline variably combined with radiotherapy. A multidisciplinary approach is essential to the successful treatment of CNHL.
Collapse
Affiliation(s)
- I Tazi
- Service d'hématologie clinique, faculté de médecine, université Cadi Ayyad, CHU Mohamed VI, Marrakech, Maroc.
| | - A Benmoussa
- Service d'hématologie clinique, faculté de médecine, université Cadi Ayyad, CHU Mohamed VI, Marrakech, Maroc
| | - F Z Boufarissi
- Service d'hématologie clinique, faculté de médecine, université Cadi Ayyad, CHU Mohamed VI, Marrakech, Maroc
| | - M Sifsalam
- Service d'hématologie clinique, faculté de médecine, université Cadi Ayyad, CHU Mohamed VI, Marrakech, Maroc
| | - F Z Lahlimi
- Service d'hématologie clinique, faculté de médecine, université Cadi Ayyad, CHU Mohamed VI, Marrakech, Maroc
| |
Collapse
|
4
|
Abstract
OBJECTIVE This study aimed to understand the population-level treatment modalities and to evaluate the survival benefits of surgical resection in primary cardiac lymphoma. METHODS We queried the Surveillance, Epidemiology, and End Results Program database, which covers 35% of the US population. Patients with a histologic diagnosis of primary cardiac lymphoma from 1973 to 2015 were included. Multivariable accelerated failure time regression was performed to evaluate the associations between clinical factors and overall survival. RESULTS A total of 184 patients were identified. The median age was 68 years, 80% were White, and 46% were women. Diffuse large B-cell lymphoma (80%) was the most common histology, and the majority (65%) was low-stage lymphoma (Ann Arbor stage I or II). Median survival was 2.2 years. Seventy-three percent of patients received chemotherapy. Only 10% of patients received local resection or debulking. Multivariable analysis demonstrated that local resection or debulking was not independently associated with overall survival (adjusted hazard ratio, 0.67; 95% confidence interval, 0.30-1.48; P = .32). Instead, chemotherapy (adjusted hazard ratio, 0.4; 95% confidence interval, 0.23-0.69; P < .001) was independently associated with improved survival, whereas increasing age (adjusted hazard ratio of 5-year increment, 1.13; 95% confidence interval, 1.04-1.22; P <.001) and advanced stage (adjusted hazard ratio, 2.18; 95% confidence interval, 1.33-3.56; P < .001) were independently associated with worse survival. CONCLUSIONS Surgical resection was not independently associated with survival in patients with primary cardiac lymphoma. Chemotherapy was the predominant treatment option and associated with improved survival, whereas increasing age and advanced stage were independently associated with worse outcomes.
Collapse
|
5
|
|
6
|
Cheng JF, Lee SH, Hsu RB, Yu SC, Shun CT, Huang PS, Chen YH, Lee CM. Fulminant primary cardiac lymphoma with sudden cardiac death: A case report and brief review. J Formos Med Assoc 2018; 117:939-943. [DOI: 10.1016/j.jfma.2018.03.011] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/22/2017] [Revised: 03/12/2018] [Accepted: 03/21/2018] [Indexed: 11/17/2022] Open
|
7
|
Endo Y, Nakamura Y, Kuroda M, Nakanishi Y, Ito Y, Hori T, Okamoto R, Konishi H. Treatment of malignant primary cardiac lymphoma with tumor resection using minimally invasive cardiac surgery. J Cardiothorac Surg 2018; 13:97. [PMID: 30257692 PMCID: PMC6158874 DOI: 10.1186/s13019-018-0778-6] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/17/2018] [Accepted: 08/27/2018] [Indexed: 11/13/2022] Open
Abstract
BACKGROUND Primary cardiac lymphoma (PCL) is extremely rare and progresses rapidly. The treatment of PCL has not yet been established. Unlike lymphoma that arises from other organs, PCL causes cardiovascular events. We report the complete remission (CR) of PCL after tumor resection using minimally invasive cardiac surgery (MICS) and chemotherapy. CASE PRESENTATION The patient was a 79-year-old man who visited our hospital with chief complaints of weight loss and leg edema. A 40 × 30 mm mobile pedunculated tumor continuous with the right ventricular heart muscle was present in the right atrium upon echocardiography and extended cardiac surgery was difficult to perform. Tumor embolism-induced sudden death was prevented and a pathological diagnosis was obtained by making a 4-cm skin incision, and tumor resection with MICS was performed through a right fourth intercostal thoracotomy with a cardiopulmonary system. The histopathological diagnosis was diffuse large B cell malignant lymphoma. Eight cycles of postoperative rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) therapy were performed. Three years after surgery, the tumor was not visible on imaging and CR was maintained. CONCLUSIONS This case highlights that tumor resection using MICS is effective for avoiding the risk of sudden death. This technique was useful for the diagnosis and treatment of a malignant cardiac tumor in an elderly patient that required a difficult extended cardiac surgery.
Collapse
Affiliation(s)
- Yuki Endo
- Department of Cardiovascular Surgery, Chiba-Nishi General Hospital, 107-1, Kanegasaku, Matsudo-shi, Chiba, 270-2251 Japan
| | - Yoshitsugu Nakamura
- Department of Cardiovascular Surgery, Chiba-Nishi General Hospital, 107-1, Kanegasaku, Matsudo-shi, Chiba, 270-2251 Japan
| | - Miho Kuroda
- Department of Cardiovascular Surgery, Chiba-Nishi General Hospital, 107-1, Kanegasaku, Matsudo-shi, Chiba, 270-2251 Japan
| | - Yusuke Nakanishi
- Department of Cardiovascular Surgery, Chiba-Nishi General Hospital, 107-1, Kanegasaku, Matsudo-shi, Chiba, 270-2251 Japan
| | - Yujiro Ito
- Department of Cardiovascular Surgery, Chiba-Nishi General Hospital, 107-1, Kanegasaku, Matsudo-shi, Chiba, 270-2251 Japan
| | - Takaki Hori
- Department of Cardiovascular Surgery, Chiba-Nishi General Hospital, 107-1, Kanegasaku, Matsudo-shi, Chiba, 270-2251 Japan
| | - Rumiko Okamoto
- Departments of Oncology, Chiba-Nishi General Hospital, 107-1, Kanegasaku, Matsudo-shi, Chiba, 270-2251 Japan
| | - Hiroshi Konishi
- Departments of Hematology, Chiba-Nishi General Hospital, 107-1, Kanegasaku, Matsudo-shi, Chiba, 270-2251 Japan
| |
Collapse
|
8
|
Primary Cardiac Lymphoma: Importance of Tissue Diagnosis. Case Rep Hematol 2018; 2018:6192452. [PMID: 30147970 PMCID: PMC6083489 DOI: 10.1155/2018/6192452] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/27/2018] [Accepted: 07/03/2018] [Indexed: 01/12/2023] Open
Abstract
Primary cardiac lymphoma (PCL) is a rare disease entity that can present with severe cardiac and cardioembolic symptoms. We present a 79-year-old male with history of polymalgia rheumatica on chronic prednisone who presented with a two-week history of progressively worsening dyspnea, cough, and a 10 pound weight loss. Transthoracic echocardiogram (TTE) and computed tomography (CT) of the chest showed a large mediastinal mass with invasion of the pericardium. A biopsy of an abdominal soft-tissue mass confirmed the diagnosis of PCL. The patient was treated with two cycles of rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) which was complicated by progressive heart failure requiring substitution of liposomal doxorubicin. The epidemiology, presentation, diagnosis, and treatment options of PCL are discussed.
Collapse
|
9
|
Fleißner F, Molitoris U, Rösler W, Kühn C. Primary Cardiac B-Non-Hodgkin Lymphoma Disguised as a Pacemaker Endocarditis. Thorac Cardiovasc Surg Rep 2018; 7:e18-e20. [PMID: 29977733 PMCID: PMC6023713 DOI: 10.1055/s-0038-1660807] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/02/2018] [Accepted: 03/21/2018] [Indexed: 10/28/2022] Open
Abstract
Background Pacemaker infections rates are high compared with the incidence of primary malignant cardiac tumors. However, they can look alike in diagnostics and patient presentation. Case Description We hereby report a rare case of a suspected pacemaker endocarditis which in fact turned out to be a primary cardiac B cell lymphoma. The lymphoma was removed surgically. Conclusion Sometimes we encounter the unexpected. Suboptimal preoperative diagnostics certainly lead to the faulty conclusion of an endocarditis. Nonetheless, even such an enhanced primary cardiac tumor can be resected with good clinical outcome and long-term survival.
Collapse
Affiliation(s)
- Felix Fleißner
- Department of Cardiac, Thoracic, Transplantation and Vascular Surgery, Hannover Medical School, Hannover, Germany.,Institute for Molecular and Translational Therapeutic Strategies (IMTTS), Hannover Medical School, Hannover, Germany
| | - Ulrich Molitoris
- Department of Cardiac, Thoracic, Transplantation and Vascular Surgery, Hannover Medical School, Hannover, Germany
| | - Wiebke Rösler
- Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany
| | - Christian Kühn
- Department of Cardiac, Thoracic, Transplantation and Vascular Surgery, Hannover Medical School, Hannover, Germany
| |
Collapse
|
10
|
|
11
|
Lee S, Yamauchi T, Kinoshita K, Imamura S, Kamiya K. High-dose chemotherapy with autologous stem cell transplantation following systemic chemotherapy, prophylactic intrathecal methotrexate, and radiotherapy prevents relapse and improves the outcome of advanced stage primary testicular lymphoma even with cardiac involvement. J Clin Exp Hematop 2017; 57:64-68. [PMID: 28883219 DOI: 10.3960/jslrt.17014] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/01/2022] Open
Abstract
Primary testicular lymphoma (PTL) is a rare but aggressive disease. Although most patients present in the early stage, their prognosis is poor. Similar with PTL, cardiac lymphoma is also an uncommon disease characterized by its aggressive clinical course and poor prognosis. We herein report an extremely rare case of advanced stage PTL with cardiac involvement, treated by high-dose chemotherapy with autologous stem cell transplantation (HDT-ASCT) followed by systemic chemotherapy, prophylactic intrathecal methotrexate (IT-MTX), and radiotherapy. A 48-year-old man presented with painless left scrotal swelling. He was diagnosed with PTL after orchiectomy, and the histological type was diffuse large B-cell lymphoma. For staging of lymphoma, positron emission tomography was performed, which revealed uptake in the right atrium and early cardiac metastasis within just 2 months after orchiectomy. He underwent 6 cycles of systemic chemotherapy that consisted of rituximab, doxorubicin, cyclophosphamide, vincristine, and prednisolone (R-CHOP). He also received central nervous system prophylaxis 4 times with weekly IT-MTX during the first 2 cycles of R-CHOP. He achieved complete response after 6 cycles of R-CHOP, and underwent HDT-ASCT and radiotherapy as consolidation therapy without irreversible adverse effects. He is currently doing well, with a progression-free survival of 31 months. The above treatment strategy including HDT-ASCT may be one of the treatment options for advanced stage PTL with cardiac metastasis in patients younger than 65 years old.
Collapse
Affiliation(s)
- Shin Lee
- Department of Hematology, Fukui Red Cross Hospital
| | - Takahiro Yamauchi
- Department of Hematology and Oncology, Faculty of Medical Sciences, University of Fukui
| | | | - Shin Imamura
- Department of Hematology, Fukui Red Cross Hospital
| | | |
Collapse
|
12
|
Földeák D, Kalapos A, Domsik P, Sinkó M, Szeleczki N, Bagdi E, Krenács L, Forster T, Borbényi Z, Nemes A. Left ventricular rigid body rotation in a diffuse large B-cell lymphoma patient with cardiac involvement: A case from the three-dimensional speckle-tracking echocardiographic MAGYAR-Path Study. REVISTA PORTUGUESA DE CARDIOLOGIA (ENGLISH EDITION) 2017. [DOI: 10.1016/j.repce.2017.02.013] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
|
13
|
Földeák D, Kalapos A, Domsik P, Sinkó M, Szeleczki N, Bagdi E, Krenács L, Forster T, Borbényi Z, Nemes A. Left ventricular rigid body rotation in a diffuse large B-cell lymphoma patient with cardiac involvement: A case from the three-dimensional speckle-tracking echocardiographic MAGYAR-Path Study. Rev Port Cardiol 2017; 36:145.e1-145.e5. [PMID: 28159427 DOI: 10.1016/j.repc.2016.04.015] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/05/2016] [Revised: 04/11/2016] [Accepted: 04/26/2016] [Indexed: 01/27/2023] Open
Abstract
Secondary myocardial involvement by diffuse large B-cell lymphoma is a rare occurrence. Left ventricular (LV) twist is considered an essential part of LV function. In normal circumstances LV twist results from the movement of two orthogonally oriented muscular bands of a helical myocardial structure with consequent clockwise rotation of the base and counterclockwise rotation of the apex. Three-dimensional (3D) speckle-tracking echocardiography (3DSTE) has been found to be feasible for non-invasive 3D quantification of LV wall motion and rotational mechanics. The present report aimed to assess LV twisting motion in a patient with diffuse large B-cell lymphoma with positron emission tomography/computer tomography-proven cardiac involvement by 3DSTE. During 3DSTE, reduction in some segmental radial, longitudinal, circumferential, area and 3D LV strains were found. Apical and basal LV rotations were found to be in the same counterclockwise direction, confirming near absence of LV twist - so-called rigid body rotation.
Collapse
Affiliation(s)
- Dóra Földeák
- Division of Haematology, 2nd Department of Medicine and Cardiology Center, Medical Faculty, Albert Szent-Györgyi Clinical Center, University of Szeged, Szeged, Hungary
| | - Anita Kalapos
- 2nd Department of Medicine and Cardiology Center, Medical Faculty, Albert Szent-Györgyi Clinical Center, University of Szeged, Szeged, Hungary
| | - Péter Domsik
- 2nd Department of Medicine and Cardiology Center, Medical Faculty, Albert Szent-Györgyi Clinical Center, University of Szeged, Szeged, Hungary
| | - Mária Sinkó
- PET/CT Centre, Bács-Kiskun County Hospital, Kecskemét, Hungary
| | - Nóra Szeleczki
- PET/CT Centre, Bács-Kiskun County Hospital, Kecskemét, Hungary
| | - Enikő Bagdi
- Laboratory of Tumor Pathology and Molecular Diagnostics, Szeged, Hungary
| | - László Krenács
- Laboratory of Tumor Pathology and Molecular Diagnostics, Szeged, Hungary
| | - Tamás Forster
- 2nd Department of Medicine and Cardiology Center, Medical Faculty, Albert Szent-Györgyi Clinical Center, University of Szeged, Szeged, Hungary
| | - Zita Borbényi
- Division of Haematology, 2nd Department of Medicine and Cardiology Center, Medical Faculty, Albert Szent-Györgyi Clinical Center, University of Szeged, Szeged, Hungary
| | - Attila Nemes
- 2nd Department of Medicine and Cardiology Center, Medical Faculty, Albert Szent-Györgyi Clinical Center, University of Szeged, Szeged, Hungary.
| |
Collapse
|
14
|
Chan O, Igwe M, Breburda CS, Amar S. Burkitt Lymphoma Presenting as an Intracardiac Mass: Case Report and Review of Literature. AMERICAN JOURNAL OF CASE REPORTS 2016; 17:553-8. [PMID: 27484990 PMCID: PMC4973801 DOI: 10.12659/ajcr.899022] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
Patient: Male, 27 Final Diagnosis: Burkitt lymphoma with intracardiac mass Symptoms: Dizziness • fatigue • palpitations • weight loss Medication: — Clinical Procedure: Catheter-directed thrombolytic therapy with intracardiac infusion of alteplase Specialty: Hematology
Collapse
Affiliation(s)
- Onyee Chan
- Department of Medicine, University of Arizona, Banner University Medical Center, Tucson, AZ, USA
| | - Michael Igwe
- Department of Medicine, Maricopa Integrated Health System, Phoenix, AZ, USA
| | | | - Surabhi Amar
- Department of Hematology Oncology, Maricopa Integrated Health System, Phoenix, AZ, USA
| |
Collapse
|
15
|
Carras S, Berger F, Chalabreysse L, Callet-Bauchut E, Cordier JF, Salles G, Girard N. Primary cardiac lymphoma: diagnosis, treatment and outcome in a modern series. Hematol Oncol 2016; 35:510-519. [PMID: 27140394 DOI: 10.1002/hon.2301] [Citation(s) in RCA: 36] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/17/2015] [Revised: 02/27/2016] [Accepted: 03/28/2016] [Indexed: 12/31/2022]
Abstract
Primary cardiac lymphoma (PCL) represents a rare subset of extranodal lymphomas for which the primary lesion arises from the heart and/or the pericardium. Fundamental characteristics of PCL remain uncertain, regarding optimal diagnosis strategy, pathological features, treatments, as well as prognostic factors. This is a single-institution retrospective study of patients with histologically proven lymphoma, presenting with exclusive or predominant myocardial invasion at time of diagnosis. Thirteen patients were included, all of whom had symptoms related to cardiac tumour location with chronic chest pain in six (46%), dyspnea in seven (54%) and arythmia in three (23%). Sub-acute and acute congestive heart failure were noticed in respectively nine (70%) and one (9%). PCL was identified at transthoracic echocardiography and computed tomography scan in 80 and 100% of patients, respectively. Most frequent location was the right atrium in 10 (77%) patients. Pericardial effusion was identified in 10 (77%). Pathological diagnosis-diffuse large B-cell lymphoma in 12 cases and Burkitt in 1 case-was made on cardiac surgical biopsies in 9 cases and by intravascular procedure in 2 cases. All patients received first-line chemotherapy, with a complete response rate of 62%. Recurrences occurred in 55% of patients, mostly at extracardiac extranodal sites. Our data confirm that PCL harbours specific clinical and anatomical features. The aggressiveness of PCL mainly results from the possible onset of acute cardiac events. Further molecular characterization may help to further individualize PCL among diffuse and intrathoracic lymphomas. Copyright © 2016 John Wiley & Sons, Ltd.
Collapse
Affiliation(s)
- Sylvain Carras
- Hospices Civils de Lyon, Université Claude Bernard Lyon 1, Service d'Hématologie, Centre Hospitalier Lyon Sud, Pierre Bénite, France
| | - Françoise Berger
- Hospices Civils de Lyon, Université Claude Bernard Lyon 1, Service d'Anatomie Pathologique, Centre Hospitalier Lyon Sud, Pierre Bénite, France
| | - Lara Chalabreysse
- Hospices Civils de Lyon, Université Claude Bernard Lyon 1, Service d'Anatomie Pathologique, Groupement Hospitalier Est, Lyon, France
| | - Evelyne Callet-Bauchut
- Hospices Civils de Lyon, Université Claude Bernard Lyon 1, Laboratoire d'Hématologie, Centre Hospitalier Lyon Sud, Pierre Bénite, France
| | - Jean-François Cordier
- Hospices Civils de Lyon, Université Claude Bernard Lyon 1, Service de Pneumologie, Hôpital Louis Pradel, Lyon, France
| | - Gilles Salles
- Hospices Civils de Lyon, Université Claude Bernard Lyon 1, Service d'Hématologie, Centre Hospitalier Lyon Sud, Pierre Bénite, France
| | - Nicolas Girard
- Hospices Civils de Lyon, Université Claude Bernard Lyon 1, Service de Pneumologie, Hôpital Louis Pradel, Lyon, France
| |
Collapse
|
16
|
Gordon MJ, Danilova O, Spurgeon S, Danilov AV. Cardiac non-Hodgkin's lymphoma: clinical characteristics and trends in survival. Eur J Haematol 2016; 97:445-452. [PMID: 26935129 DOI: 10.1111/ejh.12751] [Citation(s) in RCA: 43] [Impact Index Per Article: 5.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 03/01/2016] [Indexed: 12/22/2022]
Abstract
OBJECTIVES The purpose of this study was to describe the clinical characteristics and outcomes in cardiac non-Hodgkin's lymphoma (NHL). METHODS A retrospective analysis of 94 cases of NHL with biopsy-proven cardiac involvement in PubMed between 1990 and 2015. RESULTS Among cases with cardiac involvement, diffuse large B-cell lymphoma was the most common histologic subtype (58%), followed by T-cell lymphoma (16%), Burkitt's lymphoma (9%), and small lymphocytic lymphoma (6%). Symptomatic heart failure was the most common clinical presentation (34%), and 20% of patients had no cardiac symptoms. Median survival was 3 months (range, 0-72) among all patients. Patients who presented with heart failure had inferior outcomes. Patients with primary, vs. secondary, cardiac involvement had a trend toward superior outcomes. Importantly, chemotherapy treatment was associated with a prolongation in median survival (18 vs. 1 month, HR 0.16, 95% CI, 0.47-0.54, P = 0.0003), and patients diagnosed in the chemo-immunotherapy era demonstrated a trend toward better outcomes. Median survival was not reached among patients with B-cell malignancies who were alive for 1 month after the diagnosis. CONCLUSION Pathologic lymphomatous involvement of cardiac tissue should be considered in the evaluation of patients with NHL. Durable remissions can be achieved in B-cell NHL with cardiac involvement, and thus, therapy should be considered in such cases.
Collapse
Affiliation(s)
- Max J Gordon
- Department of Internal Medicine, Oregon Health & Sciences University, Portland, OR, USA
| | - Olga Danilova
- Pathology & Lab Medicine, VA Portland Health Care Systems, Portland, OR, USA
| | - Stephen Spurgeon
- Department of Internal Medicine, Oregon Health & Sciences University, Portland, OR, USA.,Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA
| | - Alexey V Danilov
- Department of Internal Medicine, Oregon Health & Sciences University, Portland, OR, USA. .,Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA.
| |
Collapse
|
17
|
Primary cardiac lymphoma (PCL) - diagnostic difficulties. POLISH JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY 2015; 12:266-8. [PMID: 26702288 PMCID: PMC4631924 DOI: 10.5114/kitp.2015.54468] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 12/13/2014] [Revised: 01/18/2015] [Accepted: 07/30/2015] [Indexed: 11/17/2022]
Abstract
Primary cardiac lymphoma (PCL) is the very rare disease that is associated with a high mortality rate. A prompt and proper diagnosis may affect the prognosis, and proper treatment may improve life expectancy. This report documents the case of a 74-year-old female with primary cardiac lymphoma. Unfortunately, the patient died from heart failure on her 23rd day in hospital.
Collapse
|
18
|
Rare cause of a common symptom: primary cardiac lymphoma. Am J Emerg Med 2015; 33:1849.e5-6. [DOI: 10.1016/j.ajem.2015.04.068] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/07/2015] [Accepted: 04/16/2015] [Indexed: 11/17/2022] Open
|
19
|
Montanaro C, Loiacono F, Fragasso G, De Cobelli F, Foppoli M, Margonato A. Primary Cardiac Lymphoma in an Immunocompetent 71-Year-Old Man. Tex Heart Inst J 2015; 42:561-4. [PMID: 26664312 DOI: 10.14503/thij-14-4269] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/11/2023]
Abstract
Isolated cardiac lymphomas are very rare, especially in immunocompetent patients. As a consequence, little is known about the best therapeutic management and about patients' outcomes in these cases. Diffuse large B-cell lymphoma is the most frequent subtype; anthracycline-based chemotherapy has been the most successful treatment. We describe the case of a primary cardiac lymphoma in an immunocompetent 71-year-old man. As of December 2015, the patient had been in clinical remission for 2 years. The most relevant literature on primary cardiac lymphoma is reported and discussed.
Collapse
|
20
|
Oliveira GH, Al-Kindi SG, Hoimes C, Park SJ. Characteristics and Survival of Malignant Cardiac Tumors: A 40-Year Analysis of >500 Patients. Circulation 2015; 132:2395-402. [PMID: 26467256 DOI: 10.1161/circulationaha.115.016418] [Citation(s) in RCA: 99] [Impact Index Per Article: 11.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/10/2015] [Accepted: 10/02/2015] [Indexed: 11/16/2022]
Abstract
BACKGROUND The aim of this study was to investigate the incidence, histopathology, demographics, and survival associated with primary malignant cardiac tumors (PMCTs). METHODS AND RESULTS We queried the Surveillance, Epidemiology and End Results (SEER) 18 registry from the National Cancer Institute for all PMCTs diagnosed from 1973 to 2011. We describe PMCT histopathology and incidence, comparing characteristics and survival of these patients with those of patients with extracardiac malignancies of similar histopathology. From a total of 7 384 580 cases of cancer registered in SEER, we identified 551 PMCTs (0.008%). The incidence of PMCT diagnosis is 34 cases per 100 million persons and has increased over time (25.1 in 1973-1989, 30.2 in 1990-1999, and 46.6 in 2000-2011). Most patients are female (54.1%) and white (78.6%) with median age at diagnosis of 50 years. The most common PMCTs are sarcomas (n=357, 64.8%), followed by lymphomas (n=150, 27%) and mesotheliomas (n=44, 8%). Most patients are diagnosed with tissue sample (96.8%). Although use of chemotherapy is not documented in SEER, 19% of patients received radiation and 44% had surgery. After a median follow-up of 80 months, 413 patients had died. The 1-, 3-, and 5-year survival rates were 46%, 22%, and 17% and have improved over the eras, with 1-, 3-, and 5-year survival rates of 32%, 17%, and 14% for 1973 to 1989 and 50%, 24%, and 19% for 2000 to 2011 (P=0.009). Cardiac sarcomas and mesotheliomas are the most lethal PMCTs, with 1-, 3-, 5-year survival rates of 47%, 16%, and 11% and of 51%, 26%, and 23% compared with 59%, 41%, and 34% for lymphomas, respectively (log rank test P<0.001). Patients with cardiac lymphomas and sarcomas are younger and have worse survival than patients with extracardiac disease of similar histopathology (P<0.001). CONCLUSIONS PMCTs are extremely rare and continue to be associated with poor prognosis. Over the past 5 decades, the incidence and survival of patients diagnosed with PMCT appear to have increased. Compared with those with extracardiac cancers of similar histopathology, patients with PMCTs are often younger and have worse survival.
Collapse
Affiliation(s)
- Guilherme H Oliveira
- From Onco-Cardiology Program and Advanced Heart Failure Center (G.H.O., S.G.A.) and Department of Cardiac Surgery (S.J.P.), Harrington Heart and Vascular Institute, University Hospitals Case Medical Center, Cleveland, OH; and Seidman Cancer Center and Case Western Reserve University, Cleveland, OH (G.H.O., C.H.).
| | - Sadeer G Al-Kindi
- From Onco-Cardiology Program and Advanced Heart Failure Center (G.H.O., S.G.A.) and Department of Cardiac Surgery (S.J.P.), Harrington Heart and Vascular Institute, University Hospitals Case Medical Center, Cleveland, OH; and Seidman Cancer Center and Case Western Reserve University, Cleveland, OH (G.H.O., C.H.)
| | - Christopher Hoimes
- From Onco-Cardiology Program and Advanced Heart Failure Center (G.H.O., S.G.A.) and Department of Cardiac Surgery (S.J.P.), Harrington Heart and Vascular Institute, University Hospitals Case Medical Center, Cleveland, OH; and Seidman Cancer Center and Case Western Reserve University, Cleveland, OH (G.H.O., C.H.)
| | - Soon J Park
- From Onco-Cardiology Program and Advanced Heart Failure Center (G.H.O., S.G.A.) and Department of Cardiac Surgery (S.J.P.), Harrington Heart and Vascular Institute, University Hospitals Case Medical Center, Cleveland, OH; and Seidman Cancer Center and Case Western Reserve University, Cleveland, OH (G.H.O., C.H.)
| |
Collapse
|
21
|
Riccioli V, Privitera G, Luca T, Passanisi R, Loreto C, Musumeci G, Castorina S. Collateral Circulation Resulting From Obstruction Due to Cardiac Lymphoma of Right Atrium. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA 2015; 15:e173-6. [PMID: 26385642 DOI: 10.1016/j.clml.2015.07.648] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/26/2015] [Revised: 07/24/2015] [Accepted: 07/28/2015] [Indexed: 11/27/2022]
Affiliation(s)
| | | | - Tonia Luca
- Fondazione Mediterranea "G.B. Morgagni", Catania, Italy
| | | | - Carla Loreto
- Department of Biomedical and Biotechnological Sciences, University of Catania, Italy
| | - Giuseppe Musumeci
- Department of Biomedical and Biotechnological Sciences, University of Catania, Italy
| | - Sergio Castorina
- Fondazione Mediterranea "G.B. Morgagni", Catania, Italy; Department of Biomedical and Biotechnological Sciences, University of Catania, Italy.
| |
Collapse
|
22
|
Kato Y, Kawata M, Yumura M, Suehiro H, Takada H, Matsuura T, Kamemura K, Hirayama Y, Adachi K, Matsuura A, Sakamoto S. [Case Report; A case of primary cardiac diffuse large B cell lymphoma with heart failure]. ACTA ACUST UNITED AC 2015; 104:99-102. [PMID: 26571781 DOI: 10.2169/naika.104.99] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
|
23
|
Holcman K, Cameron SJ, Laskurain E, Massey HT, Trawick DR, Mieszczanska H. Breathtaking: Platypnea-orthodeoxia syndrome. Am J Med 2014; 127:491-3. [PMID: 24608022 DOI: 10.1016/j.amjmed.2014.02.029] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/21/2013] [Revised: 02/25/2014] [Accepted: 02/25/2014] [Indexed: 11/18/2022]
Affiliation(s)
- Katarzyna Holcman
- Division of Cardiology, Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, NY
| | - Scott J Cameron
- Division of Cardiology, Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, NY
| | - Elixabeth Laskurain
- Division of Cardiology, Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, NY
| | - H Todd Massey
- Division of Cardiology, Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, NY
| | - David R Trawick
- Division of Cardiology, Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, NY
| | - Hanna Mieszczanska
- Division of Cardiology, Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, NY.
| |
Collapse
|
24
|
|
25
|
Abstract
We report a case of primary cardiac T-cell lymphoma. The diagnosis and management of this unusual primary tumor is reviewed.
Collapse
Affiliation(s)
- Bin Li
- Department of Thoracic and Cardiovascular Surgery, First Affiliated Hospital of Zhejiang University Medical School, Hangzhou, P. R. China
| | | | | | | | | | | |
Collapse
|
26
|
Anaya-Cisneros M, Tong MS, Calvo AR. Effusive-Constrictive Pericarditis Secondary to Primary Pericardial Lymphoma: A Case Report. World J Oncol 2012; 3:87-90. [PMID: 29147286 PMCID: PMC5649895 DOI: 10.4021/wjon449w] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 12/29/2011] [Indexed: 11/03/2022] Open
Abstract
Few cases of primary cardiac lymphoma (PCL) are found in the literature. We report the case of an 85 year-old male who presented with cardiac tamponade and effusive-constrictive pericarditis secondary to primary cardiac lymphoma involving only the pericardium. There have been no prior published cases with these rare scenarios.
Collapse
Affiliation(s)
- Mauricio Anaya-Cisneros
- Graduate Medical Education - Cardiovascular Medicine Fellowship, Kettering Medical Center, USA
| | - Matthew S Tong
- Internal Medicine Residency Program, Kettering Medical Center, USA
| | | |
Collapse
|
27
|
Sharma A, Minhas HS, Sakhuja P, Satsangi DK. Left Atrial Primary B Cell Lymphoma Presenting with Mitral Regurgitation. J Card Surg 2012; 27:300-3. [DOI: 10.1111/j.1540-8191.2011.01416.x] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
28
|
Iqbal Z, Sivils S, Pagel PS. Dizziness in a Patient With a Right Atrial Mass. J Cardiothorac Vasc Anesth 2012; 26:172-4. [DOI: 10.1053/j.jvca.2010.07.014] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/12/2010] [Indexed: 11/11/2022]
|
29
|
Lepeak LM, Yang DT, Chang JE. Extranodal NK/T-cell lymphoma presenting with primary cardiac involvement. Hematol Rep 2011; 3:e9. [PMID: 22184541 PMCID: PMC3238481 DOI: 10.4081/hr.2011.e9] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/09/2011] [Revised: 07/05/2011] [Accepted: 07/10/2011] [Indexed: 11/23/2022] Open
Abstract
Primary cardiac lymphoma is extremely uncommon. We report a case of a 54 year old Caucasian male with a history of non-small cell lung cancer treated by surgical resection who presented with chest pain and dyspnea on exertion. Computerized tomography (CT) imaging confirmed a 7.8×3.8 cm right atrial soft tissue mass infiltrating the lateral wall of the right atrium, and a 5 cm pericardiophrenic mass. Echocardiography confirmed a moderate pericardial effusion without tamponade physiology. Percutaneous biopsy of the pericardiophrenic mass revealed pathologic features diagnostic of NK/T-cell lymphoma. He received CHOP chemotherapy with some improvement in symptoms, but experienced radiographic progression after 2 cycles. He received palliative involved field radiotherapy but developed new sites of progressive disease within the abdomen and died shortly after completing radiotherapy. NK/T-cell lymphomas are aggressive tumors that may present with unusual extranodal disease sites. Prompt diagnosis with consideration for referral to a specialty center with experience in treatment of these rare tumors may offer the greatest potential for improving treatment outcomes.
Collapse
Affiliation(s)
- Lisa M Lepeak
- Section of Hematology and Oncology, University of Wisconsin Carbone Cancer Center, Madison, WI
| | | | | |
Collapse
|
30
|
Miguel CE, Bestetti RB. Primary cardiac lymphoma. Int J Cardiol 2011; 149:358-63. [DOI: 10.1016/j.ijcard.2010.02.016] [Citation(s) in RCA: 109] [Impact Index Per Article: 8.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/06/2009] [Revised: 02/10/2010] [Accepted: 02/10/2010] [Indexed: 11/26/2022]
|
31
|
Petrich A, Cho SI, Billett H. Primary cardiac lymphoma: an analysis of presentation, treatment, and outcome patterns. Cancer 2010; 117:581-9. [PMID: 20922788 DOI: 10.1002/cncr.25444] [Citation(s) in RCA: 210] [Impact Index Per Article: 15.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/28/2009] [Revised: 03/22/2010] [Accepted: 04/19/2010] [Indexed: 01/12/2023]
Abstract
BACKGROUND Primary cardiac lymphoma (PCL) represents a rare subset of non-Hodgkin lymphoma, characterized by poor outcomes. The authors aimed to construct a framework of known clinical presentations, diagnostic features, disease complications, treatment, and outcomes to improve prognostication. METHODS Individual patient data were obtained from defined cases of PCL (1949-2009) and systematically analyzed. RESULTS The authors report results of a review of 197 cases of PCL, with half of all cases reported since 1995. Survival was affected by 4 factors: immune status, left ventricular involvement, presence of extra-cardiac disease, and arrhythmia. Median overall survival (OS) for immunocompromised and immunocompetent was 3.5 months (m) and not reached, respectively (HR 0.29, 95% CI, 0.13-0.68; P = .004). LV involvement was uncommon (26%) and associated with an OS of only 1 m, whereas patients free of LV involvement had a median OS of 22 m (HR 0.28, 95% CI, 0.12-0.64; P = .002). Patients with extracardiac disease had shorter median OS compared with those without (6 m vs 22 m, HR 0.49, 95% CI, 0.26-0.91; P = .02). Those patients with an arrhythmia of any type had a median OS that was not reached (n = 55), whereas those without rhythm disturbances (n = 41) had median OS of 6 m (HR 0.51, 95% CI, 0.29-0.91; P = .024). Overall response rate to therapy was 84%, with long-term OS over 40%. CONCLUSIONS The current study presents the largest analysis of PCL to date. The data demonstrate that PCL is now more frequently diagnosed premortem and appears to have reasonable response rates. Lack of LV involvement and the presence of arrhythmias are associated with improved survival.
Collapse
Affiliation(s)
- Adam Petrich
- Department of Oncology, Montefiore Medical Center, Bronx, New York 10467, USA.
| | | | | |
Collapse
|
32
|
Riberi A, Gariboldi V, Grisoli D, Collart F. [Cardiac tumors]. REVUE DE PNEUMOLOGIE CLINIQUE 2010; 66:95-103. [PMID: 20207301 DOI: 10.1016/j.pneumo.2009.12.012] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/17/2009] [Accepted: 12/17/2009] [Indexed: 05/28/2023]
Abstract
Primary cardiac tumor is a rare disease, with an incidence ranging from 0.001 to 0.03%. Eighty percent of them are benign tumors, and among them 70% are myxomas, the others are: fibroelastoma, rhabdomyoma, fibroma, angioma and lipoma. Primary malignant tumors of heart are in 95% of cases sarcomas, the remaining 5% are lymphomas. Cardiac's metastases are more frequent than primary tumors. Diagnosis is made by echocardiography TAC and MRI. Whereas surgery is indicated in patients with benign tumors, or localised sarcomas, chemotherapy in those with widespread disease and radiotherapy and chemotherapy in lymphoma. Prognosis is excellent in benign cardiac tumor. Mean survival for sarcomas is 11 months, and lymphoma 5 years.
Collapse
Affiliation(s)
- A Riberi
- Service de Chirurgie Cardiaque Adulte, Hôpital de la Timone, 264 rue Saint-Pierre, 13005 Marseille, France
| | | | | | | |
Collapse
|
33
|
Chin JY, Chung MH, Kim JJ, Lee JH, Kim JH, Maeng IH, Jung SY, Hwang HJ, Lee JB, Youn HJ. Extensive primary cardiac lymphoma diagnosed by percutaneous endomyocardial biopsy. J Cardiovasc Ultrasound 2009; 17:141-4. [PMID: 20661340 DOI: 10.4250/jcu.2009.17.4.141] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/16/2009] [Revised: 11/30/2009] [Accepted: 11/30/2009] [Indexed: 11/22/2022] Open
Abstract
Primary cardiac lymphoma (PCL) is an extranodal non-Hodgkin's lymphoma exclusively located in the heart and/or pericardium. It is rare in immunocompetent patients and represents 1.3% of primary cardiac tumors and 0.5% of extranodal lymphomas. The clinical behavior is aggressive and the early symptoms are cardiac failure, syncope, arrhythmia, or pericardial effusion. Although echocardiography, computed tomography (CT) scan, magnetic resonance image (MRI) are the mainly used imaging techniques to detect cardiac tumors, pathologic examination is always required to confirm the diagnosis. Diagnosis of PCL is difficult due to non-specific clinical manifestations and requires invasive approach to get histopathologic evidence. While surgery with systemic chemotherapy or in combination with irradiation has been attempted, the only effective treatment is chemotherapy. However, the prognosis remains poor. We report on a 42-year-old woman who is diagnosed histopathologically as PCL by cardiac catheterization assisted percutaneous endomyocardial biopsy and treated successfully by anthracycline based chemotherapy.
Collapse
Affiliation(s)
- Jung Yeon Chin
- Division of Cardiology, Department of Internal Medicine, School of Medicine, The Catholic University of Korea, St. Mary's Hospital, Seoul, Korea
| | | | | | | | | | | | | | | | | | | |
Collapse
|
34
|
Abstract
Lymphomas arising in extranodal sites are intriguing. The types of lymphomas encountered vary widely from one extranodal site to another. For many types of extranodal lymphomas, there are distinctive clinicopathologic features, sometimes including association with an underlying immunodeficiency syndrome, autoimmune disease, infection, or other immunologic disorder, or a predilection to affect patients of certain ethnic origins. Presented below is a review of lymphomas that are encountered most often in extranodal sites.
Collapse
Affiliation(s)
- Judith A Ferry
- Department of Pathology, Massachusetts General Hospital, 55 Fruit St, Boston, MA 02114, USA.
| |
Collapse
|
35
|
Faganello G, Belham M, Thaman R, Blundell J, Eller T, Wilde P. A case of primary cardiac lymphoma: analysis of the role of echocardiography in early diagnosis. Echocardiography 2008; 24:889-92. [PMID: 17767544 DOI: 10.1111/j.1540-8175.2007.00472.x] [Citation(s) in RCA: 27] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/05/2023] Open
Abstract
Primary Cardiac Lymphoma (PCL) is defined as a non-Hodgkin's lymphoma involving only the heart and/or pericardium. Diagnosis of this rare disease is particularly difficult due to its nonspecific clinical manifestations. In this review the role of echocardiography in the early diagnosis of PCL is assessed, moreover we report an improvement in the outcome of PCL related to increased availability and utilization of echocardiography.
Collapse
Affiliation(s)
- Giorgio Faganello
- Bristol Heart Institute, Upper Maudlin Street, Bristol Royal Infirmary, Bristol, UK.
| | | | | | | | | | | |
Collapse
|
36
|
Chiu KM, Lin TY, Li SJ, Chan CY, Chu SH. Surgical resection of primary cardiac lymphoma. ACTA ACUST UNITED AC 2006; 6:420-1. [PMID: 16640823 DOI: 10.3816/clm.2006.n.023] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
Primary cardiac lymphoma is a rare cardiac malignancy. Surgical resection is rarely performed on this disease entity. We report a case of primary cardiac lymphoma with rapid progression. Debulking surgery was done extensively before final pathology was obtained. Complete remission was exhibited after several courses of chemotherapy.
Collapse
Affiliation(s)
- Kuan-Ming Chiu
- Department of Cardiovascular Surgery, Far-Eastern Memorial Hospital, Taipei, Taiwan
| | | | | | | | | |
Collapse
|
37
|
Abstract
Primary cardiac lymphoma (PCL) has rarely been reported in Chinese populations. PCL mostly occurs in the right atrium. The clinical manifestations may be variable and are attributed to its location, the presence of congestive heart failure, pericardial effusion, arrhythmia, and cardiomegaly. The prognosis is usually poor because it is usually found too late and therefore, clinicians should be aware of PCL. Imaging examinations are the best methods for initial diagnosis and include echocardiography, computed tomography (CT) scan, magnetic resonance imaging (MRI), and radioisotope scan. However, the final diagnosis is made by pathology, such as cytologic examination of the effusive fluid and tissue biopsy. Because the tumors are difficult to resect, the main treatment for the disease is chemotherapy, which can be successful. Here, we report a 58-year-old man who had a tumor measuring 8 x 5 cm in the right atrium. By clinical staging, including chest X-ray, echocardiography, CT scan of the abdomen, MRI of the heart, whole body tumor Gallium scan, and gastrointestinal series, no metastatic lesion or involvement was found in other parts of the body. Pathologic findings including cytology of pericardial effusion and heart tumor biopsy revealed the case as a diffuse large B-cell lymphoma. After chemotherapy with COP (cyclophosphamide + vincristine + prednisone) and CHOPBE (COP + doxorubicin + bleomycin + etoposide) regimens, the intracardiac tumor had disappeared, but the patient survived for 12 months in total, despite additional radiotherapy over the pericardial lesions. It was presumed that because the tumor was very large and involved all 3 layers of the heart, it did not respond as well to the therapy as expected.
Collapse
Affiliation(s)
- Shu-Ching Hsueh
- Division of Hematology/Oncology, Department of Internal Medicine, Cheng-Hsin Rehabilitation and Medical Center, Taipei, Taiwan, ROC.
| | | | | | | | | | | |
Collapse
|
38
|
Abstract
Bronchogenic cysts are classified as a type of congenital foregut cyst. They are usually extrapulmonary and occur mostly along the tracheobronchial tree. Intracardiac bronchogenic cysts are very rare. As far as we know, only 3 cases have been reported previously. This paper presents a unique case of a 70-year-old male who was diagnosed with a bronchogenic cyst in the interatrial septum with a concomitant persistent left superior vena cava. He underwent successful complete excision of the cyst under cardiopulmonary bypass and enjoyed an uneventful life with normal sinus rhythm during the 1-year follow-up. The relevant literature is reviewed and an explanation for the embryogenesis of the bronchogenic cyst in such a peculiar location is proposed.
Collapse
Affiliation(s)
- Chien-Chang Chen
- Division of Cardiovascular Surgery, Department of Surgery, Chi-Mei Medical Center, Tainan, Taiwan, ROC.
| |
Collapse
|
39
|
Abstract
Primary cardiac tumours are rare, with an autopsy incidence ranging from 0.001% to 0.030%. Three-quarters of these tumours are benign and nearly half of the benign tumours are myxomas. Metastases to the heart are far more common than primary cardiac tumours. Primary cardiac tumours present with one or more of the symptoms of the classic triad of: cardiac symptoms and signs resulting from intracardiac obstruction; signs of systemic embolisation; and systemic or constitutional symptoms. They are diagnosed by use of transthoracic and transoesophageal echocardiograms, MRI, and CT scan. Whereas surgery is indicated in patients with benign tumours, systemic chemotherapy is indicated in those who have widespread or unresectable malignant disease, and chemotherapy and radiotherapy are usually combined in treatment of patients with primary cardiac lymphomas. The prognosis after surgery is usually excellent in the case of benign tumours but is unfortunately still limited in localised malignant diseases. Patients with sarcomas live for a mean of 3 months to 1 year, and those with lymphomas live up to 5 years if treated, but usually die within 1 month if untreated.
Collapse
|
40
|
Takenaka S, Mitsudo K, Inoue K, Goto T, Kadota K, Fujii S, Yamamoto H, Fuku Y, Hirono A, Tanaka H, Taba M, Ikeda A, Kojima Y, Maekawa J, Maekawa S, Takahashi N, Saeki H, Nakamura Y, Oonishi T, Ueda N. Successful Treatment of Primary Cardiac Lymphoma With Atrioventricular Nodal Block. Int Heart J 2005; 46:927-31. [PMID: 16272785 DOI: 10.1536/ihj.46.927] [Citation(s) in RCA: 16] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]
Abstract
A 69-year-old female suffering from third-degree atrioventricular block with syncope underwent permanent pacemaker implantation. However, she developed shortness of breath 2 months after the implantation. Blood tests revealed elevated levels of LDH, CRP, BNP, and SIL-2R. Transthoracic echocardiography showed thickened left and right atrial walls with mild pericardial effusion. A diagnosis was made based on a CT scan and histology. Although most primary cardiac malignant lymphomas are associated with a poor prognosis, the patient was treated successfully with chemotherapy.
Collapse
Affiliation(s)
- Sou Takenaka
- Department of Cardiology, Kurashiki Central Hospital, Miwa, Okayama, Japan
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|